| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.70B | +4.6% |
| R&D Expense | $67.0M | -14.5% |
| SG&A Expense | $616.8M | -4.4% |
| Operating Income | $375.9M | +105.0% |
| Interest Expense | $138.7M | -11.8% |
| Pre-tax Income | $68.9M | -65.2% |
| Income Tax | $105.4M | -5.1% |
| Net Income | -$107.2M | -906.0% |
| EPS (Basic) | -$0.24 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.06B | -20.4% |
| Accounts Receivable | $966.5M | +6.0% |
| Inventory | $1.04B | +0.8% |
| Current Assets | $4.99B | -6.6% |
| Total Assets | $9.44B | -5.7% |
| Current Liabilities | $4.17B | +8.4% |
| Long-term Debt | $1.37B | -31.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $352.1M | -54.9% |
| Capital Expenditures | $157.9M | -17.6% |
| Investing Cash Flow | $162.2M | -80.2% |
| Financing Cash Flow | -$796.7M | +84.3% |
| Free Cash Flow | $194.2M | -67.1% |
| -900.0% |
| EPS (Diluted) | -$0.24 | -900.0% |
| Total Liabilities |
| $6.17B |
| -6.6% |
| Stockholders' Equity | $3.24B | -4.8% |